Michał Chojnicki (Ewa Deskur-Śmielecka)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Decision Making

Respiratory Syndrome Coronavirus

Top Venues

Medical science monitor : international medical journal of experimental and clinical research

International journal of environmental research and public health

The American journal of bioethics : AJOB

This page only lists publications with an associated author ORCID identifier.

Publications

Tomasz Rzepiński, Michał Chojnicki, Michał Chojnicki
Machine Learning Algorithms in the Personalized Modeling of Incapacitated Patients' Decision Making-Is It a Viable Concept? The American journal of bioethics : AJOB 24 (7) (2024)
Mateusz de Mezer, Jan Rogaliński, Stanisław Przewoźny, Michał Chojnicki, Leszek Niepolski, Magdalena Sobieska, Agnieszka Przystańska
SERPINA3: Stimulator or Inhibitor of Pathological Changes. Biomedicines 11 (1) (2023)
Mateusz de Mezer, Jan Rogaliński, Stanisław Przewoźny, Michał Chojnicki, Leszek Niepolski, Magdalena Sobieska, Agnieszka Przystańska
SERPINA3: Stimulator or Inhibitor of Pathological Changes. Biomedicines 11 (1) (2023)
Łukasz Goździewicz, Sławomir Tobis, Michał Chojnicki, Jerzy Chudek, Katarzyna Wieczorowska-Tobis, Ilona Idasiak-Piechocka, Piotr Merks, Urszula Religioni, Agnieszka Neumann-Podczaska
Long-Term Impairment in Activities of Daily Living Following COVID-19 in Residents of Long-Term Care Facilities. Medical science monitor : international medical journal of experimental and clinical research 29 (2023)
Michał Chojnicki, Agnieszka Neumann-Podczaska, Mikołaj Seostianin, Zofia Tomczak, Hamza Tariq, Jerzy Chudek, Sławomir Tobis, Iwona Mozer-Lisewska, Aleksandra Suwalska, Andrzej Tykarski, Piotr Merks, Sylwia Kropińska, Małgorzata Sobieszczańska, Frank Romanelli, Katarzyna Wieczorowska-Tobis
Long-Term Survival of Older Patients Hospitalized for COVID-19. Do Clinical Characteristics upon Admission Matter? International journal of environmental research and public health 18 (20) (2021)